Home
Services
Our Team
Hot Topics/News
Philosophy
Testimonials
Contact Us
Site Map
|
Diagnostics Project Leadership
Beginning in 1982, Dr. Eileen Gorman has worked to develop signal amplification technology, clinical assays and assays fully integrated with instrument systems. She has been responsible for commercialization of many successful products.
- Homogenous and heterogeneous assay formats allow detection across a broad range of concentrations.
- Experience includes therapeutic drug monitoring, specific protein assays, and
abused drugs.
- Technology assessment and business planning.
| Product
Developed |
Business
Impact |
|
| Tobramycin
assay |
Kit
format, later transferred to Dimension®
clinical
analyzer system continues in use today, more than 10 years
after initial introduction. |
|
| C-reactive
protein assay |
Kit
format, later transferred to Dimension®
clinical
analyzer system and aca®
discrete
clinical analyzer continues in use today, more than 10 years
after initial introduction. |
Patented
technology developed. |
| Calibrator
for 8 drugs of abuse |
Single,
multi analyte calibrator for use with 8 drugs of abuse
developed. Gives
customer state of the art in performance and ease of use. |
|
| Troponin
I calibrator |
Product
Marketed. |
|
Dimension®
and aca® are registered trademarks of Dade Behring.
|
|
|
55 New Montgomery Street, Suite 605
San Francisco, CA 94105
TEL 415 362-0442
FAX 415 536-2871
5 Bisbee Court, Suite
109-225
Santa Fe, NM 87508-1419
TEL 505-473-2703
FAX 505-474-9032
Copyright © DNA Bridges®, Inc.
2000-2008, ALL RIGHTS RESERVED.
LEGAL NOTICES
AND DISCLAIMERS |
